SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-267369
Filing Date
2021-09-08
Accepted
2021-09-08 08:47:04
Documents
14
Period of Report
2021-09-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d220150d8k.htm   iXBRL 8-K 38893
2 EX-99.1 d220150dex991.htm EX-99.1 16909
  Complete submission text file 0001193125-21-267369.txt   237996

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA srngu-20210908.xsd EX-101.SCH 4898
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srngu-20210908_def.xml EX-101.DEF 14676
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE srngu-20210908_lab.xml EX-101.LAB 24956
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srngu-20210908_pre.xml EX-101.PRE 15711
7 EXTRACTED XBRL INSTANCE DOCUMENT d220150d8k_htm.xml XML 7525
Mailing Address 955 FIFTH AVENUE NEW YORK NY 10075
Business Address 955 FIFTH AVENUE NEW YORK NY 10075 (310) 209-7280
Soaring Eagle Acquisition Corp. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 211240825
SIC: 2836 Biological Products, (No Diagnostic Substances)